Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure

NCT03821701 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Chronic Heart Failure

Interventions

DRUG: Entresto
DRUG: ACEI/ARB

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Collaborators

[object Object]